Literature DB >> 25456692

Association of quality of life with anticoagulant control in patients with heart failure: the Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) trial.

Jonathan A Shaffer, John L P Thompson, Bin Cheng, Siqin Ye, Gregory Y H Lip, Douglas L Mann, Ralph L Sacco, Patrick M Pullicino, Ronald S Freudenberger, Susan Graham, J P Mohr, Arthur J Labovitz, Conrado J Estol, Dirk J Lok, Piotr Ponikowski, Stefan D Anker, Marco R Di Tullio, Shunichi Homma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25456692      PMCID： PMC4303491          DOI： 10.1016/j.ijcard.2014.10.012

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  9 in total

1.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff
Journal:  J Am Coll Cardiol       Date:  2013-06-05       Impact factor: 24.094

2.  Impact of adherence, knowledge, and quality of life on anticoagulation control.

Authors:  Nichola J Davis; Henny H Billett; Hillel W Cohen; Julia H Arnsten
Journal:  Ann Pharmacother       Date:  2005-02-15       Impact factor: 3.154

3.  Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables.

Authors:  J Juenger; D Schellberg; S Kraemer; A Haunstetter; C Zugck; W Herzog; M Haass
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

4.  Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA).

Authors:  A J Rose; E M Hylek; A Ozonoff; A S Ash; J I Reisman; D R Berlowitz
Journal:  J Thromb Haemost       Date:  2010-10       Impact factor: 5.824

5.  Warfarin and aspirin in patients with heart failure and sinus rhythm.

Authors:  Shunichi Homma; John L P Thompson; Patrick M Pullicino; Bruce Levin; Ronald S Freudenberger; John R Teerlink; Susan E Ammon; Susan Graham; Ralph L Sacco; Douglas L Mann; J P Mohr; Barry M Massie; Arthur J Labovitz; Stefan D Anker; Dirk J Lok; Piotr Ponikowski; Conrado J Estol; Gregory Y H Lip; Marco R Di Tullio; Alexandra R Sanford; Vilma Mejia; Andre P Gabriel; Mirna L del Valle; Richard Buchsbaum
Journal:  N Engl J Med       Date:  2012-05-02       Impact factor: 91.245

6.  Assessing relationships between health-related quality of life and adherence to antiretroviral therapy.

Authors:  E Carballo; C Cadarso-Suárez; I Carrera; J Fraga; J de la Fuente; A Ocampo; R Ojea; A Prieto
Journal:  Qual Life Res       Date:  2004-04       Impact factor: 4.147

7.  A method to determine the optimal intensity of oral anticoagulant therapy.

Authors:  F R Rosendaal; S C Cannegieter; F J van der Meer; E Briët
Journal:  Thromb Haemost       Date:  1993-03-01       Impact factor: 5.249

8.  Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score.

Authors:  Stavros Apostolakis; Renee M Sullivan; Brian Olshansky; Gregory Y H Lip
Journal:  Chest       Date:  2013-11       Impact factor: 9.410

Review 9.  Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review.

Authors:  Yi Wan; Carl Heneghan; Rafael Perera; Nia Roberts; Jennifer Hollowell; Paul Glasziou; Clare Bankhead; Yongyong Xu
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2008-11-05
  9 in total
  1 in total

Review 1.  Anticoagulation in Heart Failure: a Review.

Authors:  Emily P Zeitler; Zubin J Eapen
Journal:  J Atr Fibrillation       Date:  2015-06-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.